News
Benzinga on MSN18m
Novo Nordisk Jumps After FDA Grants Wegovy Approval For Liver Fibrosis, Unlocking Billions In Market Potential
Novo Nordisk shares rose Friday after the FDA granted accelerated approval for Wegovy to treat liver fibrosis in adults, ...
Expanded approval of Wegovy was based on results from the Phase III ESSENCE trial (NCT04822181), which demonstrated ...
Major U.S. equities indexes were little changed Monday morning, ahead of retail sector earnings reports and comments from ...
Novo Nordisk's weight-loss treatment Wegovy gained U.S. approval to treat a progressive liver condition on Friday, as the Danish drugmaker looks to boost sales and widen insurance coverage. Eli ...
Novo Nordisk is working with GoodRx to offer a month’s supply of Ozempic for $499, or about half the list price, for self-paying patients. Ozempic, a drug approved for Type 2 diabetes, cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback